Novartis CEO discusses how AI will impact drug development

Поділитися
Вставка
  • Опубліковано 25 гру 2024

КОМЕНТАРІ • 4

  • @WhereTechMeetsBio
    @WhereTechMeetsBio 10 місяців тому +4

    How he is so sure AI won't impact early drug discovery within 5 years? We will have clinical trial stats on AI-designed candidates within next 2-4 years and companies like Insilico Medicine are showing already today that it is possible to get results with AI quickly and for more tx areas at once.

    • @squamish4244
      @squamish4244 6 місяців тому +1

      AI has already created a potential new drug, a year ago, for liver cancer. So maybe he's being conservative in his estimates. Or maybe the pipeline really is that long due to human trials and it will taken ten years to produce a bunch of new drugs. I'd be very surprised if in ten years, we do NOT have a bunch of new AI-discovered drugs, however.

  • @gitricspot20vsion30
    @gitricspot20vsion30 Місяць тому +1

    what a poor guy 😢

  • @solidhg2005
    @solidhg2005 3 місяці тому +2

    What pipeline, how does it even run out?